A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins

• Main Authors: Alberico L. Catapano MD, PhD (Author), Michal Vrablik MD, PhD (Author), Yuri Karpov MD (Author), Baptiste Berthou Lic (Author), Megan Loy BAppSc (Author), Marie Baccara-Dinet MD (Author)
• 格式: 圖書
• 出版: SAGE Publishing, 2022-11-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Objective: In primary hypercholesterolemia many people treated with statins do not reach their plasma LDL-C goals and are at increased risk of cardiovascular disease (CVD). This study aimed to evaluate efficacy and safety of a new fixed-dose combination (FDC) formulation of rosuvastatin/ezetimibe (R...